| Name | Title | Contact Details |
|---|---|---|
Nicholas Koutrakos |
CFO | Profile |
Arise Health Plan is a De Pere, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Baird Nursing Home is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
With a track record of transformative leadership in healthcare technology, Figueroa will spearhead our efforts to integrate cutting-edge technology, streamline operations, and enhance patient care across our extensive network of community-based clinics.As a dynamic leader, Figueroa brings a wealth of experience in leveraging technology to optimize healthcare delivery. His strategic vision aligns perfectly with our commitment to providing the best possible care to our patients. He will play a pivotal role in advancing our digital infrastructure, fostering innovation, and ultimately, improving outcomes for those we serve.
Live Better Hearing + Balance is a premier audiology practice with locations throughout the Mid Atlantic. They provide a full range of audiology services for all ages with appropriate, medically & scientifically sound testing & treatment options.
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.